Evidence map›Paper›PMID 32983093›Full record

ReviewFrontiers in immunology2020

Impact of

Garance Coquant, Jean-Pierre Grill, Philippe Seksik

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Direct Maxillary Sinus Tissue Analysis forJournal of clinical medicine · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Regulation of drug resistance to enrofloxacin inFrontiers in microbiology · 2026
    Article
  7. Article
  8. First Evidence of Metabolically Active Intracellular Bacteria inJournal of agricultural and food chemistry · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Regulation of ofloxacin resistance inFrontiers in veterinary science · 2025
    Article
  13. Review
  14. A human gutScience (New York, N.Y.) · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Garance CoquantSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Hôpital Saint Antoine, Paris, France.
Jean-Pierre GrillSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Hôpital Saint Antoine, Paris, France.
Philippe SeksikSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Hôpital Saint Antoine, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among numerous molecules found in the gut ecosystem, quorum sensing (QS) molecules represent an overlooked part that warrants highlighting. QS relies on the release of small molecules (auto-inducers) by bacteria that accumulate in the environment depending on bacterial cell density. These molecules not only are sensed by the microbial community but also interact with host cells and contribute to gut homeostasis. It therefore appears entirely appropriate to highlight the role of these molecules on the immune system in dysbiosis-associated inflammatory conditions where the bacterial populations are imbalanced. Here, we intent to focus on one of the most studied QS molecule family, namely, the type I auto-inducers represented by

Indexed as

Gastrointestinal MicrobiomeImmunity, MucosalQuorum Sensing4-ButyrolactoneAcyl-ButyrolactonesAdaptive ImmunityAnimalsBacteriaHost-Pathogen InteractionsHumansImmunity, InnateIntestinal MucosaSignal Transduction4-ButyrolactoneAcyl-Butyrolactoneshomoserine lactonegut inflammationgut microbiotainflammatory bowel diseaseinterkingdom communicationquorum sensing

Identifiers

PMID32983093
PMCPMC7484616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.